LIXT (STOCKS)

    Lixte Biotechnology Holdings, Inc. Common Stock

    $2.930000
    -0.120000 (-3.93%)
    Prev close: $3.050000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Geordan G. Pursglove
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $34.33M
    Employees
    4
    P/E (TTM)
    -2.38
    P/B (TTM)
    3.38
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Dec 2024 (Q4)
    $-0.27 $0.00 +0.0000 +0.00%
    Financial Statements
    TTM (Dec 2025)
    Revenues $0.00
    Operating Expenses $5.11M
    Research and Development $254.92K
    Other Operating Expenses $4.85M
    Operating Income/Loss -$5.11M
    Income/Loss From Continuing Operations After Tax -$6.01M
    Income/Loss From Continuing Operations Before Tax -$6.01M
    Interest Expense, Operating $9.16K
    Net Income/Loss -$6.01M
    Net Income/Loss Attributable To Noncontrolling Interest $69.07K
    Net Income/Loss Attributable To Parent -$6.08M
    Net Income/Loss Available To Common Stockholders, Basic -$6.08M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Diluted Earnings Per Share -$1.26
    Diluted Average Shares 4,840,731
    Assets $12.73M
    Current Assets $5.18M
    Noncurrent Assets $7.56M
    Liabilities $1.77M
    Current Liabilities $1.33M
    Noncurrent Liabilities $438.96K
    Equity $10.96M
    Equity Attributable To Noncontrolling Interest $1.30M
    Equity Attributable To Parent $9.66M
    Liabilities And Equity $12.73M
    Net Cash Flow From Operating Activities -$3.07M
    Net Cash Flow From Operating Activities, Continuing -$3.07M
    Net Cash Flow -$3.07M
    Net Cash Flow, Continuing -$3.07M
    Comprehensive Income/Loss -$6.01M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$6.01M
    Other Comprehensive Income/Loss $0.00